Insider Selling: Teladoc Health, Inc. (NYSE:TDOC) Insider Sells $92,712.62 in Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now directly owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Teladoc Health Trading Up 3.1 %

NYSE:TDOC opened at $8.43 on Monday. The company has a 50-day moving average price of $10.42 and a 200-day moving average price of $9.76. The stock has a market cap of $1.46 billion, a price-to-earnings ratio of -1.46 and a beta of 1.27. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 12 month low of $6.76 and a 12 month high of $15.43.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Equities analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Institutional Trading of Teladoc Health

Hedge funds and other institutional investors have recently modified their holdings of the business. Arizona State Retirement System boosted its stake in Teladoc Health by 1.8% during the fourth quarter. Arizona State Retirement System now owns 49,691 shares of the health services provider’s stock worth $452,000 after acquiring an additional 859 shares in the last quarter. Mercer Global Advisors Inc. ADV boosted its position in shares of Teladoc Health by 9.6% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider’s stock worth $113,000 after purchasing an additional 1,089 shares in the last quarter. Canada Pension Plan Investment Board grew its stake in shares of Teladoc Health by 0.5% in the 4th quarter. Canada Pension Plan Investment Board now owns 228,700 shares of the health services provider’s stock worth $2,079,000 after buying an additional 1,200 shares during the last quarter. Summit Investment Advisors Inc. increased its position in Teladoc Health by 8.0% during the 4th quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider’s stock valued at $164,000 after buying an additional 1,331 shares in the last quarter. Finally, Vise Technologies Inc. raised its stake in Teladoc Health by 4.9% during the fourth quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider’s stock valued at $274,000 after buying an additional 1,405 shares during the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on TDOC shares. Oppenheimer decreased their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. Piper Sandler decreased their price objective on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a report on Thursday, February 27th. Bank of America lifted their price target on Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research note on Wednesday, February 12th. Finally, Royal Bank of Canada increased their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $11.26.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.